Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Position Summary Postdoctoral Research Associate in Molecular Imaging and Therapy A postdoctoral research position is available at Mallinckrodt Institute of Radiology (MIR), Precision
-
Tesla MR systems, three 64-detector multidetector CT scanners, two dedicated neurointerventional angio suites and two PET-CT. Teaching and mentoring of medical students, residents and fellows is also a
-
- PETVISION "Next generation Limited-Angle time-of-flight PET imager". Gross salary per year: 38.140,24 €. The application period is from October 27 to November 7, 2025. Where to apply Website https://t.ly
-
#CA-DK Under the general direction of the Radiology Manager, the incumbent is responsible for supervisory and leadership aspects of all Magnetic Resonance Imaging services for Hospital Radiology
-
iteratively refine each strategy, thereby maximizing both scientific impact and translational potential. Responsibilities Design multifunctional nanoplatforms (organic, inorganic, hybrid) for image-guided (PET
-
: https://facultyaffairs.oregonstate.edu/out-cycle-tenure-review-procedure . The Carlson College of Veterinary Medicine provides professional and graduate programs for veterinary students leading to DVM, MS
-
University of California Irvine Health | Los Alamitos, California | United States | about 1 month ago
Diagnostic Imaging, the Nuclear Medicine Technologist is directly responsible for maintaining a safe and efficient nuclear medicine department using radioactive isotopes for enhanced diagnostic imaging. He/she
-
, PET/CT, SPECT/CT) and image-guided and targeted radiation therapy (XRad, MultiRad). Key Responsibilities: Collaborate with and support Principal Investigators (PI) and other Animal Imaging Irradiation
-
equivalent) in Psychology, Neuroscience, or a related field. Candidates should have strong skills in statistics. Programming skills (e.g., Python) and experience with PET or MRI imaging and data analysis
-
our NINDS U19 Center Without Walls, a multidisciplinary program advancing next-generation radiopharmaceuticals for imaging targets such as alpha-synucleinopathies and 4R tauopathies, which spans